[EN] KRAS G12C INHIBITORS AND METHODS OF USING THE SAME<br/>[FR] INHIBITEURS DE KRAS G12C ET LEURS PROCÉDÉS D'UTILISATION
申请人:AMGEN INC
公开号:WO2018119183A2
公开(公告)日:2018-06-28
Provided herein are KRAS G12C inhibitors, composition of the same, and methods of using the same. These inhibitors are useful for treating a number of disorders, including pancreatic, colorectal, and lung cancers.